Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Notable 52-Week Highs and Lows of the Day 06/08: (SGEN) (NEON) (DG) High; (ANR) (ACI) (AUO) Low
-
Cantor Fitzgerald Maintains a 'Hold' on Kroger (KR); Cutting Estimates Ahead of Q1 Report
-
Cantor Fitzgerald Starts Cypress Semi (CY) at Sell; Competition May Ruin the Touch-SoC Party
-
Cantor Fitzgerald Starts Ligand Pharma (LGND) at Buy; Fundamentally Undervalued; Building Momentum In 2012
-
Cantor Fitzgerald Starts Neonode (NEON) at Buy; Expecting Tier-One Wins For Printers and Handsets
-
Cantor Fitzgerald Maintains a 'Sell' on United Natural Foods (UNFI); Operating Cash Flow Appears Insufficient
-
Cantor Fitzgerald Raises PT and Estimates on NewLink Genetics (NLNK); Great Data at ASCO
-
Cantor Fitzgerald Upgrades Equity LifeStyle Properties (ELS) to Buy; Starting To Look Like A Bargain
-
Cantor Fitzgerald Maintains a 'Buy' on Obagi Medical Products (OMPI); Volatility Expected Around Shareholder Meeting
-
Cantor Fitzgerald Reiterates a 'Buy' on Sirona Dental (SIRO); Discounted Valuation Fails to Account for Vast Underpenetration Worldwide
-
Notable Analyst Rating Changes 06/04: (BAC) (ABMD) (STI) Upgraded; (RF) (SCHW) (HOT) Downgraded
-
Cantor Fitzgerald Starts Galena Biopharma (GALE) at Buy; New Approach to Breast Cancer
-
Post Properties (PPS) Files To Sell Up to 4M Shares
-
Cantor Fitzgerald Starts Cross Country Healthcare (CCRN) at Buy; Improved Fundamentals
-
Canaccord Genuity Morning Coffee on JP Morgan (JPM): Look Out Below!
-
Cantor Fitzgerald Starts Align Technology (ALGN) at Buy, $37 Price Target
-
Cantor Fitzgerald Starts Sirona Dental (SIRO) at Buy, $57 Price Target
-
Notable Analyst Rating Changes 05/18: (MS) (MM) (PBR) Upgraded; (CAVM) (PWER) (CY) Downgraded
-
Cantor Fitzgerald Downgrades Power-One (PWER) to Hold; Near-Term Uncertainty From Department of Commerce Decision
-
Cantor Fitzgerald Downgrades Satcon Technology (SATC) to Hold; Near-Term Uncertainty From Department of Commerce Decision
-
Cantor Fitzgerald Maintains a 'Hold' on Medicis (MRX); Looking For The Accretive Transaction
-
Notable Mergers and Acquisitions of the Day 05/09: (BBBY)/(CPWM) (GSK)/(HGSI) (NKBP)
-
Westinghouse Solar, CBD Energy Enter All-Stock Merger Agreement
-
Cantor Fitzgerald Downgrades Endo Pharmaceuticals (ENDP) to Hold; Sidelined Ahead of Lidoderm Decision; M&A Unlikely N-T
-
Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official
-
Cantor Fitzgerald Maintains a 'Hold' on Hologic (HOLX); Acquisition Overshadows Challenging Quarter
-
Notable Analyst Rating Changes 04/20: (CCJ) (REXX) (NOK) Upgraded; (RVBD) (FHN) (BAC) Downgraded
-
Cantor Fitzgerald Downgrades Riverbed Technology (RVBD) to Hold; More Questions Than Answers
-
Cantor Fitzgerald Slightly Lowers Numbers on Cree (CREE), But Feels Q3 Miss Is Buying Opportunity
-
Cantor Fitzgerald Maintains a 'Hold' on Medicis (MRX); Adjusting Numbers
-
Cantor Fitzgerald Cuts Price Target on Illumina (ILMN); Roche Walks
-
Cantor Fitzgerald Maintains a 'Hold' on Intuitive Surgical (ISRG); Raising Numbers, But Not Looking To Chase Shares
-
Cantor Fitzgerald Maintains a 'Buy' on Forest Laboratories (FRX); Raising PT and Estimates
-
Notable Analyst Rating Changes 04/18: (DECK) (PCX) (FSLR) Upgraded; (IBM) (CREE) (DNB) Downgraded
-
Cantor Fitzgerald Upgrades First Solar (FSLR) to Hold; Easy Short Call Done; Looking for A Little Luck
-
Cantor Fitzgerald Starts Cerus (CERS) at Buy; Potential Game-Changer in Blood
-
Morning Movers 04/13: (PRMW) (JOEZ) (CSTR) Higher; (PWAV) (NEI) (JADE) Lower
-
Cantor Fitzgerald Starts Sunesis Pharmaceuticals (SNSS) at Buy
-
Cantor Fitzgerald Positive on Satcon Technology (SATC) After Investor Update; Suggests Accumulating Shares at Current Levels
-
Analyst Says Buy the Weakness in Endo Pharma (ENDP) Shares Amid Vancocin Concerns
-
Cantor Fitzgerald Maintains a 'Buy' on Salix Pharmaceuticals (SLXP); Suggests Buying Into Weakness
-
Cantor Fitzgerald Starts Marriott Vacations Worldwide (VAC) at Buy; Considering A Timeshare
-
Unusual 11 Mid-Day Movers 04/09: (AOL) (IBIO) (CALL) Higher; (MOH) (ITMN) (CNC) Lower
-
Morning Movers 04/09: (AOL) (CALL) (WOLF) Higher; (MOH) (CKSW) (CNC) (PATK) Lower
-
Cantor Fitzgerald Downgrades Molina Healthcare (MOH) to Hold; Renewal in Ohio Failed
-
Notable Analyst Rating Changes 04/05: (WU) (LQDT) (PAY) Upgraded; (CIEN) (ASBC) (LNKD) Downgraded
-
Galena (GALE) Prices 8.5M Offering at $1.50/Share
-
Cantor Fitzgerald Raises Price Target on Pernix Therapeutics (PTX) After Positive Management Meeting
-
Cantor Fitzgerald Starts Ventrus Biosciences (VTUS) at Buy; N-T Binary Play
-
Cantor Fitzgerald Starts NVIDIA (NVDA) at Buy; Leading Developer of GPUs

